← Evidence map

ArticleDrug safety2001

Risk-benefit assessment of glatiramer acetate in multiple sclerosis.

T Ziemssen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

25 papers cite it

2001
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 11735654